SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 31.2 CNY -2.26%
Market Cap: 13.5B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SonoScape Medical Corp
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Selling, General & Administrative
-ÂĄ775.4m
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Selling, General & Administrative
-ÂĄ384.3m
CAGR 3-Years
-35%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Selling, General & Administrative
-ÂĄ1.6B
CAGR 3-Years
-9%
CAGR 5-Years
-13%
CAGR 10-Years
-18%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Selling, General & Administrative
-ÂĄ7.3B
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Selling, General & Administrative
-ÂĄ881.6m
CAGR 3-Years
-10%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Selling, General & Administrative
-ÂĄ2.4B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
13.4B CNY
Industry
Health Care

SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.

Intrinsic Value
49.55 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Selling, General & Administrative?
Selling, General & Administrative
-775.4m CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Selling, General & Administrative amounts to -775.4m CNY.

What is SonoScape Medical Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-10%

Over the last year, the Selling, General & Administrative growth was -27%. The average annual Selling, General & Administrative growth rates for SonoScape Medical Corp have been -19% over the past three years , -10% over the past five years .

Back to Top